Cargando…

The management of schizophrenia: focus on extended-release quetiapine fumarate

Effective management of schizophrenia remains a significant clinical challenge. While antipsychotic medications have proven efficacy in this disease, there remains an opportunity to further improve symptom control and long-term relapse prevention. Also, a number of factors, including tolerability an...

Descripción completa

Detalles Bibliográficos
Autor principal:	Peuskens, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191868/ https://www.ncbi.nlm.nih.gov/pubmed/22003295 http://dx.doi.org/10.2147/NDT.S3380

Ejemplares similares

Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili, Nizar
Publicado: (2012)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2008)

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
por: Ulloa, Carol M, et al.
Publicado: (2009)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Gajwani, Prashant, et al.
Publicado: (2007)

Management of obsessive-compulsive disorder with fluvoxamine extended release
por: Ordacgi, Lídia, et al.
Publicado: (2009)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007)

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
por: Mundo, Emanuela, et al.
Publicado: (2006)

Carbamazepine extended-release capsules in bipolar disorder
por: Weisler, Richard H
Publicado: (2006)

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
por: Stoner, Steven C, et al.
Publicado: (2007)

Emerging role of sertindole in the management of schizophrenia
por: Cincotta, Stephanie L, et al.
Publicado: (2010)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Stafstrom, Carl E
Publicado: (2009)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Domnitei, Diana, et al.
Publicado: (2010)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease
por: Cuomo, Arturo, et al.
Publicado: (2019)

Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations
por: Kibbe, AH, et al.
Publicado: (2018)

Once-monthly paliperidone injection for the treatment of schizophrenia
por: Bishara, Delia
Publicado: (2010)

Zolpidem modified-release in insomnia
por: Kirkwood, Cynthia, et al.
Publicado: (2007)

Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia
por: Akhlaq, Muhammad, et al.
Publicado: (2018)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Bishop, Jeffrey R, et al.
Publicado: (2008)

Emerging treatments for premature ejaculation: focus on dapoxetine
por: Hellstrom, Wayne JG
Publicado: (2009)

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder
por: Citrome, Leslie
Publicado: (2006)

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
por: Wang, Gang, et al.
Publicado: (2014)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: Nelson, J Craig, et al.
Publicado: (2008)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: Lindenmayer, JP
Publicado: (2010)

Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
por: Frille, Armin, et al.
Publicado: (2020)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
por: Di Lorenzo, Rosaria, et al.
Publicado: (2010)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri, Giancarlo, et al.
Publicado: (2019)

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini, Francesco, et al.
Publicado: (2019)

Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies
por: Arnautovska, Urska, et al.
Publicado: (2022)

Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009)

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
por: Kutcher, Stan, et al.
Publicado: (2005)

Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Maloney, Ann E, et al.
Publicado: (2010)

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations
por: Fujii, Akira, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_eep7et6h50noa06698ubqh7bvr